Phone messages aim to break stigma and boost HIV prevention in kazakhstan
NCT ID NCT07508137
First seen Apr 10, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study tests a short digital messaging program (via Telegram or WhatsApp) to help people who use drugs in Kazakhstan overcome stigma and learn about PrEP, a medicine that prevents HIV. About 40 participants will receive informational messages over 2-3 weeks and complete surveys. No drugs or medical procedures are involved—the goal is to see if the program is acceptable and useful.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Center for Scientific and Practical Initiatives
Almaty, Kazakhstan
Contact
Conditions
Explore the condition pages connected to this study.